Partha Sarathi Mukherjee

Dr. Partha Sarathi Mukherjee


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
STSathyanarayana Tamysetty
Sathyanarayana Tamysetty
GBGiridhara R Babu
Giridhara R Babu
BSBiswamitra Sahu
Biswamitra Sahu
SSSuresh Shapeti
Suresh Shapeti
DRDeepa Ravi
Deepa Ravi
SKSonalini Khetrapal
Sonalini Khetrapal
There are limited studies on COVID vaccine confidence at the household level in urban slums, which are at high risk of COVID-19 transmission due to overcrowding and poor living conditions. The objective was to understand the reasons influencing COVID-19 vaccine confidence, in terms of barriers and enablers faced by communities in urban slums and informal settlements in four major metro cities in India. A mixed method approach was adopted, where in field studies were conducted during April–May 2021. First, a survey of at least 50 subjects was conducted among residents of informal urban settlements who had not taken any dose of the COVID-19 vaccine in Mumbai, Bengaluru, Kolkata and Delhi; second, a short interview with five subjects who had taken at least one dose of the vaccine in each of the four cities to understand the factors that contributed to positive behaviour and, finally, an in-depth interview of at least 3 key informants in each city to ascertain the vaccination pattern in the communities. The reasons were grouped under contextual, individual/group and vaccine/vaccination specific issues. The most frequent reason (27.7%) was the uncertainty of getting the vaccine. The findings show the need for increasing effectiveness of awareness campaigns, accessibility and the convenience of vaccination, especially among vulnerable groups, to increase the uptake.

4 October 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
PTPoshan Thapa
Poshan Thapa
PNPadmanesan Narasimhan
Padmanesan Narasimhan
RJRohan Jayasuriya
Rohan Jayasuriya
JHJohn J. Hall
John J. Hall
PMPartha Sarathi Mukherjee
Partha Sarathi Mukherjee
KBKristen Beek
Kristen Beek
India has a high burden of Tuberculosis (TB), accounting for a significant portion of global cases. While efforts are being made to engage the formal private sector in the National TB Elimination Program (NTEP) of India, there remains a significant gap in addressing the engagement of Informal Healthcare Providers (IPs), who serve as the first point of contact for healthcare in many communities. Recognizing the increasing evidence of IPs’ importance in TB care, it is crucial to enhance their engagement in the NTEP. Therefore, this study explored various factors influencing the engagement of IPs in the program. A qualitative study was conducted in West Bengal, India, involving 23 IPs and 11 Formal Providers (FPs) from different levels of the formal health system. Thematic analysis of the data was conducted following a six-step approach outlined by Braun and Clarke. Three overarching themes were identified in the analysis, encompassing barriers and facilitators to IPs’ engagement in the NTEP. The first theme focused on IPs’ position and capacity as care providers, highlighting their role as primary care providers and the trust and acceptance extended by the community. The second theme explored policy and system-level drivers and prohibitors, revealing barriers such as role ambiguity, competing tasks, and quality of care issues. Facilitators such as growing recognition of IPs’ importance in the health system, an inclusive incentive system, and willingness to collaborate were also identified. The third theme focused on the relationship between the formal and informal systems, highlighting a need to strengthen the relationship between the two. This study sheds light on factors influencing the engagement of IPs in the NTEP of India. It emphasizes the need for role clarity, knowledge enhancement, and improved relationships between formal and informal systems. By addressing these factors, policymakers and stakeholders can strengthen the engagement of IPs in the NTEP.

3 August 2022 in Health Policy and Planning
Verified
Journal Article
Closed access
PDF file
PTPoshan Thapa
Poshan Thapa
JHJohn J Hall
John J Hall
RJRohan Jayasuriya
Rohan Jayasuriya
PMPartha Sarathi Mukherjee
Partha Sarathi Mukherjee
KBKristen M Beek
Kristen M Beek
PNPadmanesan Narasimhan
Padmanesan Narasimhan
India is the highest TB burden country, accounting for an estimated 26% of the global TB cases. Systematic engagement of the private sector is a cornerstone of India’s National Strategic Plan for TB Elimination (2017–25). However, informal healthcare providers (IPs), who are the first point of contact for a large number of TB patients, remain significantly underutilized in the National TB Elimination Program of India. Non-prioritization of IPs has also resulted in a limited understanding of their TB care practices in the community. We, therefore, undertook a descriptive study to document IPs’ TB care practices, primarily focusing on their approach to screening, diagnosis, treatment and referral. This cross-sectional study was carried out from February to March 2020 in the Birbhum District of West Bengal, India. Interviews were conducted utilizing the retrospective case study method. A total of 203 IPs participated who reported seeing at least one confirmed TB patient in 6 months prior to the study. In that duration, IPs reported interacting with an average of five suspected TB cases, two of which were later confirmed as having TB. Antibiotic use was found to be common among IPs (highest 69% during the first visit); however, they were prescribed before the patient was suspected or confirmed as having TB. We noted the practice of prolonged treatment among IPs as patients were prescribed medicines until the second follow-up visit. Referral was the preferred TB case management approach among IPs, but delayed referral was observed, with only one-third (34%) of patients being referred to higher health facilities during their first visit. This study presents important findings on IPs’ TB care practices, which have consequences for achieving India’s national goal of TB elimination.

8 September 2022 in International Journal of Hepatology
Verified
Journal Article
Open access
PDF file
ASAmal Santra
Amal Santra
DBDebasree Bishnu
Debasree Bishnu
SSSuman Santra
Suman Santra
SGSubhadip Ghatak
Subhadip Ghatak
PMPartha Sarathi Mukherjee
Partha Sarathi Mukherjee
ACAbhijit Chowdhury
Abhijit Chowdhury
Background and Aims. The cellular mechanism of liver injury related to arsenic toxicity is ill defined. It is thought that oxidative stress and mitochondrial dysfunction may play some role in arsenic-induced liver damage. In this study, we evaluated subcellular events within the primary cultured mouse hepatocytes when exposed to inorganic arsenic. Methods. Primary cultured mouse hepatocytes were treated with 10μM arsenic for different time periods. Reactive oxygen species (ROS) formation, functional changes of the lysosome and mitochondria, and mode of hepatocytes death were studied by laser confocal microscopy, fluorescence spectroscopy, and flow cytometry. Expression of proapoptotic member of the BCL-2 family of genes BAX and antiapoptotic BCL-2 mRNA expression were studied by real-time PCR. Cytochrome c expression was studied by Western blotting. Results. Fluorescence spectroscopy as well as flow cytometric analysis revealed that arsenic-induced formation of ROS was time dependent. Confocal microscopy showed initiation of ROS formation from periphery of the hepatocytes at 30min of arsenic exposure that progressed to central part of the hepatocytes at 3h of arsenic exposure. The ROS formation was found to be NADPH oxidase (NOX) dependent. This low level of intracellular ROS induced lysosomal membrane permeabilization (LMP) and subsequently released cathepsin B to the cytosol. The LMP further increased intracellular ROS which in turn triggered induction of mitochondrial permeability transition (MPT). Pretreatment of hepatocytes with LMP inhibitor bafilomycin A (BafA) significantly decreased, and LMP inducer chloroquine (ChQ) significantly increased the production of ROS suggesting that LMP preceded enhanced ROS generation in response to arsenic. MPT was accompanied with increase in BAX:BCL2 mRNA ratio resulting in upregulation of caspase 3 and increased hepatocyte apoptosis. Conclusion. Although arsenic-related oxidative liver injury is well established, neither the site of origin of ROS nor the early sequence of events in arsenic toxicity due to ROS is known. We believe that our study provides evidences elucidating the early sequence of events that culminates in the death of the mouse hepatocytes during arsenic exposure.

30 July 2022 in International Health
Verified
Journal Article
Open access
PDF file
PTPoshan Thapa
Poshan Thapa
RJRohan Jayasuriya
Rohan Jayasuriya
JHJohn J Hall
John J Hall
PMPartha Sarathi Mukherjee
Partha Sarathi Mukherjee
KBKristen M Beek
Kristen M Beek
PNPadmanesan Narasimhan
Padmanesan Narasimhan
Background: India accounts for one-quarter of the world's TB cases. Despite efforts to engage the private sector in India's National TB Elimination Program, informal healthcare providers (IPs), who serve as the first contact for a significant TB patients, remain grossly underutilised. However, considering the substantial evidence establishing IPs' role in patients' care pathway, it is essential to expand the evidence base regarding their knowledge in TB care. Methods: We conducted a cross-sectional study in the Birbhum district of West Bengal, India. The data were collected using the TB vignette among 331 IPs (165 trained and 166 untrained). The correct case management was defined following India's Technical and Operational Guidelines for TB Control. Results: Overall, IPs demonstrated a suboptimal level of knowledge in TB care. IPs exhibited the lowest knowledge in asking essential history questions (all four: 5.4% and at least two: 21.7%) compared with ordering sputum test (76.1%), making a correct diagnosis (83.3%) and appropriate referrals (100%). Nonetheless, a statistically significant difference in knowledge (in most domains of TB care) was observed between trained and untrained IPs. Conclusions: This study identifies gaps in IPs' knowledge in TB care. However, the observed significant difference between the trained and untrained groups indicates a positive impact of training in improving IPs’ knowledge in TB care.

26 May 2020 in International Journal of Diabetes in Developing Countries
Verified
Journal Article
Closed access
PDF file
PMPartha Sarathi Mukherjee
Partha Sarathi Mukherjee
SGSujoy Ghosh
Sujoy Ghosh
PMPradip Mukhopadhyay
Pradip Mukhopadhyay
KDKausik Das
Kausik Das
DDDipesh Kr. Das
Dipesh Kr. Das
KCKajal Chatterjee
Kajal Chatterjee